| Yaneka Rhea Alaimalo, NP | |
|
400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 | |
| (757) 345-4300 | |
| (757) 510-9190 |
| Full Name | Yaneka Rhea Alaimalo |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Acute Care |
| Location | 400 Sentara Cir Ste 320, Williamsburg, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033631734 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2100X | Nurse Practitioner - Acute Care | SP018096 (Pennsylvania) | Secondary |
| 363LA2100X | Nurse Practitioner - Acute Care | 0024174617 (Virginia) | Primary |
| Entity Name | Pinnacle Health Medical Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932143427 PECOS PAC ID: 7618960493 Enrollment ID: O20040407000180 |
News Archive
A team of scientists from Immanuel Kant Baltic Federal University used Raman spectroscopy to study the thrombocytes of patients with cardiovascular diseases and compared their spectra with those of healthy people.
A new approach tested by researchers at the University of Iowa shows that de-identified data from a "smart thermometer" connected to a mobile phone app can track flu activity in real time at both population and individual levels and the data can be used to significantly improve flu forecasting.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
| Entity Name | Pinnacle Health Hospitalist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023458148 PECOS PAC ID: 9739313545 Enrollment ID: O20131010001079 |
News Archive
A team of scientists from Immanuel Kant Baltic Federal University used Raman spectroscopy to study the thrombocytes of patients with cardiovascular diseases and compared their spectra with those of healthy people.
A new approach tested by researchers at the University of Iowa shows that de-identified data from a "smart thermometer" connected to a mobile phone app can track flu activity in real time at both population and individual levels and the data can be used to significantly improve flu forecasting.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
| Entity Name | Pinnacle Health Regional Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013441690 PECOS PAC ID: 7416228358 Enrollment ID: O20170810001731 |
News Archive
A team of scientists from Immanuel Kant Baltic Federal University used Raman spectroscopy to study the thrombocytes of patients with cardiovascular diseases and compared their spectra with those of healthy people.
A new approach tested by researchers at the University of Iowa shows that de-identified data from a "smart thermometer" connected to a mobile phone app can track flu activity in real time at both population and individual levels and the data can be used to significantly improve flu forecasting.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yaneka Rhea Alaimalo, NP 400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 Ph: (757) 345-4300 | Yaneka Rhea Alaimalo, NP 400 Sentara Cir Ste 320, Williamsburg, VA 23188-5716 Ph: (757) 345-4300 |
News Archive
A team of scientists from Immanuel Kant Baltic Federal University used Raman spectroscopy to study the thrombocytes of patients with cardiovascular diseases and compared their spectra with those of healthy people.
A new approach tested by researchers at the University of Iowa shows that de-identified data from a "smart thermometer" connected to a mobile phone app can track flu activity in real time at both population and individual levels and the data can be used to significantly improve flu forecasting.
ImpactRx, Inc., the pioneering force in measuring the impact of pharmaceutical promotion on the behavior of the nation's highest prescribing physicians, today announced the launch of an application for physicians that provides pharmaceutical companies with timely and actionable insight into drug therapy promotion and treatment activity. ImpactRx is leveraging the capabilities of this newly available smart-phone application by using iPhone with its longitudinal physician network.
Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, has received approval from the U.S. Food and Drug Administration for Dyloject (diclofenac sodium) Injection, a proprietary nonsteroidal anti-inflammatory drug (NSAID) analgesic.
› Verified 7 days ago
Mrs. Keva Walker, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1235 S Mount Vernon Ave, Williamsburg, VA 23185 Phone: 757-229-4122 | |
Mrs. Leah Meister Childress, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1144 Professional Dr, Williamsburg, VA 23185 Phone: 757-259-0443 Fax: 757-259-0450 | |
Manju Treesa Jose, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5436 Burlington Ct, Williamsburg, VA 23188 Phone: 757-968-0936 | |
Julie Andrews, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 4601 Ironbound Rd, Williamsburg, VA 23188 Phone: 757-253-5161 | |
Michelle Hoffmann, ACNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5000 New Point Rd Ste 2301, Williamsburg, VA 23188 Phone: 757-201-9771 | |
Morlinda M Kruegel, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 120 Kings Way, Suite 3500, Williamsburg, VA 23185 Phone: 757-221-0110 Fax: 757-221-0851 |